Skip to main content
Clinical Trials/NCT03278756
NCT03278756
Completed
Not Applicable

Online Cognitive Control Training for Remitted Depressed Patients

University Ghent1 site in 1 country68 target enrollmentSeptember 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Major Depression in Remission
Sponsor
University Ghent
Enrollment
68
Locations
1
Primary Endpoint
Change in depressive symptomatology
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study evaluates the effectiveness of an internet-delivered cognitive control training as a preventive intervention for remitted depressed patients. Half of the participants will receive a cognitive control training, while the other half will receive a low cognitive load training that acts as an active control condition.

Detailed Description

Prospective studies have linked impaired cognitive control to increased cognitive vulnerability for future depression. Importantly, experimental studies indicate that cognitive control training can be used to reduce rumination and depressive symptomatology in MDD (major depressive disorder) and RMD (remitted depressed) samples. Provided that remitted depressed patients form a high-risk group for developing future depressive episodes, the current study will explore whether an internet-delivered cognitive control training can be used to reduce vulnerability for future depression in remitted depressed patients. A computer training, consisting of 10 sessions of 15 minutes each, will be administered to participants, which are remitted depressed patients. This training can either be a cognitive control training, using an adaptive paced auditory serial addition task, or an active control training, with a low cognitive load task. Dependent variables will be assessed pre- and post-training, as well as 3 and 6 months after the training, and consist of depressive symptomatology, related variables and cognitive control measures.

Registry
clinicaltrials.gov
Start Date
September 1, 2017
End Date
March 13, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • History of ≥ 1 depressive episodes (major or bipolar)
  • Currently in stable full or partial remission (≥ 3 months)

Exclusion Criteria

  • Major depressive disorder (current or less than 3 months in remission)
  • Bipolar disorder (current or less than 3 months in remission)
  • Psychotic disorder (current and/or previous)
  • Neurological impairments (current and/or previous)
  • Excessive substance abuse (current and/or previous)
  • No ongoing psychotherapeutic treatment (maintenance treatment is allowed, but with a frequency of less than once every three weeks)
  • Use of antidepressant medication is allowed if kept at a constant level

Outcomes

Primary Outcomes

Change in depressive symptomatology

Time Frame: Assessed at pre-training assessment, at post-training assessment (within 1 week of completing the training), at 3 months follow-up and at 6 months follow-up

Measured by the Depression Anxiety Stress Scales (DASS)

Change in depressive rumination (brooding)

Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Measured by the Ruminative Response Scale (RRS), especially the brooding subscale

Secondary Outcomes

  • Change in cognitive emotion regulation strategies(Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up)
  • Resilience(Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up)
  • Change in quality of life(Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up)
  • Remission from depression(Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up)

Study Sites (1)

Loading locations...

Similar Trials